Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 108

1.

Burden of Nocturnal Hypoxia and Type of Positive Airway Pressure Therapy May Influence Markers of Acute Kidney Injury in Patients With Obstructive Sleep Apnea.

Voulgaris A, Nena E, Steiropoulos P.

J Clin Sleep Med. 2019 Oct 1. pii: jc-19-00251. [Epub ahead of print] No abstract available.

PMID:
31571575
2.

Increased risk for cardiovascular disease in patients with obstructive sleep apnoea syndrome-chronic obstructive pulmonary disease (overlap syndrome).

Voulgaris A, Archontogeorgis K, Papanas N, Pilitsi E, Nena E, Xanthoudaki M, Mikhailidis DP, Froudarakis ME, Steiropoulos P.

Clin Respir J. 2019 Aug 21. doi: 10.1111/crj.13078. [Epub ahead of print]

PMID:
31433558
3.

Postoperative high flow nasal insufflation for obstructive sleep apnea: potential therapeutic alternative or prudence needed?

Diaz-Abad M, Steiropoulos P, Esquinas AM.

Korean J Anesthesiol. 2019 Aug 20. doi: 10.4097/kja.19337. [Epub ahead of print] No abstract available.

4.

Chronic kidney disease in patients with obstructive sleep apnea. A narrative review.

Voulgaris A, Marrone O, Bonsignore MR, Steiropoulos P.

Sleep Med Rev. 2019 Oct;47:74-89. doi: 10.1016/j.smrv.2019.07.001. Epub 2019 Jul 5. Review.

PMID:
31376590
5.

Investigation of the relationship between sleep disorders and xerostomia.

Apessos I, Andreadis D, Steiropoulos P, Tortopidis D, Angelis L.

Clin Oral Investig. 2019 Aug 2. doi: 10.1007/s00784-019-03029-1. [Epub ahead of print]

PMID:
31372830
6.

Unique sleep-stage transitions determined by obstructive sleep apnea severity, age and gender.

Wächter M, Kantelhardt JW, Bonsignore MR, Bouloukaki I, Escourrou P, Fietze I, Grote L, Korzybski D, Lombardi C, Marrone O, Paranicova I, Pataka A, Ryan S, Schiza SE, Sliwinski P, Steiropoulos P, Verbraecken J, Penzel T; ESADA Study Group.

J Sleep Res. 2019 Jul 25:e12895. doi: 10.1111/jsr.12895. [Epub ahead of print]

PMID:
31347213
7.

Elevated Levels of Alveolar Nitric Oxide May Indicate Presence of Small Airway Inflammation in Patients with Inflammatory Bowel Disease.

Protopapas AA, Vradelis S, Karampitsakos T, Steiropoulos P, Chatzimichael A, Paraskakis E.

Lung. 2019 Oct;197(5):663-670. doi: 10.1007/s00408-019-00253-0. Epub 2019 Jul 17.

PMID:
31317255
8.

Reduced Serum Vitamin D Levels Are Associated with Insulin Resistance in Patients with Obstructive Sleep Apnea Syndrome.

Archontogeorgis K, Papanas N, Rizos EC, Nena E, Zissimopoulos A, Tsigalou C, Voulgaris A, Mikhailidis DP, Elisaf MS, Froudarakis ME, Steiropoulos P.

Medicina (Kaunas). 2019 May 20;55(5). pii: E174. doi: 10.3390/medicina55050174.

9.

Cancer prevalence is increased in females with sleep apnoea: data from the ESADA study.

Pataka A, Bonsignore MR, Ryan S, Riha RL, Pepin JL, Schiza S, Basoglu OK, Sliwinski P, Ludka O, Steiropoulos P, Anttalainen U, McNicholas WT, Hedner J, Grote L; ESADA study group.

Eur Respir J. 2019 Jun 20;53(6). pii: 1900091. doi: 10.1183/13993003.00091-2019. Print 2019 Jun. No abstract available.

PMID:
31109987
10.

Clinical Characteristics of Obstructive Sleep Apnea in Psychiatric Disease.

Knechtle B, Economou NT, Nikolaidis PT, Velentza L, Kallianos A, Steiropoulos P, Koutsompolis D, Rosemann T, Trakada G.

J Clin Med. 2019 Apr 18;8(4). pii: E534. doi: 10.3390/jcm8040534.

11.

Detection of mild cognitive impairment in middle-aged and older adults with obstructive sleep apnoea: does excessive daytime sleepiness play a role?

Steiropoulos P, Galbiati A, Ferini-Strambi L.

Eur Respir J. 2019 Jan 3;53(1). pii: 1801917. doi: 10.1183/13993003.01917-2018. Print 2019 Jan. No abstract available.

PMID:
30606763
12.

Genetics of Obstructive Sleep Apnea: Vitamin D Receptor Gene Variation Affects Both Vitamin D Serum Concentration and Disease Susceptibility.

Ragia G, Archontogeorgis K, Simmaco M, Gentile G, Borro M, Zissimopoulos A, Froudarakis M, Manolopoulos VG, Steiropoulos P.

OMICS. 2019 Jan;23(1):45-53. doi: 10.1089/omi.2018.0184. Epub 2018 Dec 18.

PMID:
30562127
13.

Use of the Clinical Global Impression scale in sleep apnea patients - Results from the ESADA database.

Dieltjens M, Verbraecken JA, Hedner J, Vanderveken OM, Steiropoulos P, Kvamme JA, Saaresranta T, Tkacova R, Marrone O, Dogas Z, Schiza S, Grote L; ESADA collaborators.

Sleep Med. 2019 Jul;59:56-65. doi: 10.1016/j.sleep.2018.10.028. Epub 2018 Nov 14.

PMID:
30555029
14.

Lung function changes after chemoradiation therapy in patients with lung cancer treated by three usual platinum combinations.

Mihailidis V, Anevlavis S, Karpathiou G, Kouliatsis G, Tzouvelekis A, Zarogoulidis P, Ntolios P, Steiropoulos P, Bouros D, Froudarakis ME.

J Thorac Dis. 2018 Sep;10(9):5435-5442. doi: 10.21037/jtd.2018.08.139.

15.

Comment on: Comorbidities in coexisting chronic obstructive pulmonary disease and obstructive sleep apnea - overlap syndrome.

Voulgaris A, Nena E, Steiropoulos P.

Eur Rev Med Pharmacol Sci. 2018 Oct;22(19):6171-6172. doi: 10.26355/eurrev_201810_16020. No abstract available.

16.

Association of Asthma and Allergic Rhinitis With Sleep-Disordered Breathing in Childhood.

Perikleous E, Steiropoulos P, Nena E, Iordanidou M, Tzouvelekis A, Chatzimichael A, Paraskakis E.

Front Pediatr. 2018 Sep 11;6:250. doi: 10.3389/fped.2018.00250. eCollection 2018.

17.

The role of vitamin D in obstructive sleep apnoea syndrome.

Archontogeorgis K, Nena E, Papanas N, Steiropoulos P.

Breathe (Sheff). 2018 Sep;14(3):206-215. doi: 10.1183/20734735.000618. Review.

18.

Mean Platelet Volume and Platelet Distribution Width in Patients With Obstructive Sleep Apnea Syndrome and Concurrent Chronic Obstructive Pulmonary Disease.

Archontogeorgis K, Voulgaris A, Papanas N, Nena E, Froudarakis M, Mikhailidis DP, Steiropoulos P.

Clin Appl Thromb Hemost. 2018 Nov;24(8):1216-1222. doi: 10.1177/1076029618788178. Epub 2018 Jul 17.

19.

Clinical presentation of patients with suspected obstructive sleep apnea and self-reported physician-diagnosed asthma in the ESADA cohort.

Bonsignore MR, Pepin JL, Anttalainen U, Schiza SE, Basoglu OK, Pataka A, Steiropoulos P, Dogas Z, Grote L, Hedner J, McNicholas WT, Marrone O; ESADA Study Group.

J Sleep Res. 2018 Dec;27(6):e12729. doi: 10.1111/jsr.12729. Epub 2018 Jul 11.

PMID:
29998568
20.

Serum levels of NGAL and cystatin C as markers of early kidney dysfunction in patients with obstructive sleep apnea syndrome.

Voulgaris A, Archontogeorgis K, Nena E, Tsigalou C, Xanthoudaki M, Kouratzi M, Tripsianis G, Froudarakis M, Steiropoulos P.

Sleep Breath. 2019 Mar;23(1):161-169. doi: 10.1007/s11325-018-1677-8. Epub 2018 Jun 26.

PMID:
29946947
21.

Cardiovascular disease and obstructive sleep apnea: an underappreciated role for increased platelet activity?

Steiropoulos P, Voulgaris A, Papanas N.

Expert Opin Pharmacother. 2018 Jul;19(10):1043-1044. doi: 10.1080/14656566.2018.1491242. Epub 2018 Jun 29. No abstract available.

PMID:
29924660
22.

DNA Methylation in Pediatric Obstructive Sleep Apnea: An Overview of Preliminary Findings.

Perikleous E, Steiropoulos P, Tzouvelekis A, Nena E, Koffa M, Paraskakis E.

Front Pediatr. 2018 May 29;6:154. doi: 10.3389/fped.2018.00154. eCollection 2018. Review.

23.

Sleep-Related Drug Therapy in Special Conditions: Children.

Economou NT, Ferini-Strambi L, Steiropoulos P.

Sleep Med Clin. 2018 Jun;13(2):251-262. doi: 10.1016/j.jsmc.2018.02.007. Review.

PMID:
29759275
24.

Effect of Shift Work on Sleep, Health, and Quality of Life of Health-care Workers.

Nena E, Katsaouni M, Steiropoulos P, Theodorou E, Constantinidis TC, Tripsianis G.

Indian J Occup Environ Med. 2018 Jan-Apr;22(1):29-34. doi: 10.4103/ijoem.IJOEM_4_18.

25.

Cardiovascular Risk Assessment in a Cohort of Newly Diagnosed Patients with Obstructive Sleep Apnea Syndrome.

Archontogeorgis K, Voulgaris A, Nena E, Strempela M, Karailidou P, Tzouvelekis A, Mouemin T, Xanthoudaki M, Steiropoulos S, Froudarakis ME, Steiropoulos P.

Cardiol Res Pract. 2018 Mar 8;2018:6572785. doi: 10.1155/2018/6572785. eCollection 2018.

26.

E-Cigarette Use Among Adolescents: An Overview of the Literature and Future Perspectives.

Perikleous EP, Steiropoulos P, Paraskakis E, Constantinidis TC, Nena E.

Front Public Health. 2018 Mar 26;6:86. doi: 10.3389/fpubh.2018.00086. eCollection 2018. Review.

27.

Metabolic Syndrome and Vitamin D Levels in Patients with Obstructive Sleep Apnea Syndrome.

Archontogeorgis K, Nena E, Papanas N, Rizzo M, Voulgaris A, Xanthoudaki M, Kouratzi M, Ragia G, Manolopoulos V, Zissimopoulos A, Froudarakis M, Steiropoulos P.

Metab Syndr Relat Disord. 2018 May;16(4):190-196. doi: 10.1089/met.2017.0181. Epub 2018 Apr 2.

PMID:
29608396
28.

Longitudinal outcomes of patients enrolled in a phase Ib clinical trial of the adipose-derived stromal cells-stromal vascular fraction in idiopathic pulmonary fibrosis.

Ntolios P, Manoloudi E, Tzouvelekis A, Bouros E, Steiropoulos P, Anevlavis S, Bouros D, Froudarakis ME.

Clin Respir J. 2018 Jun;12(6):2084-2089. doi: 10.1111/crj.12777. Epub 2018 Mar 12.

PMID:
29412521
29.

Insulin Sensitivity and Insulin Resistance in Non-Diabetic Middle-Aged Patients with Obstructive Sleep Apnoea Syndrome.

Archontogeorgis K, Papanas N, Nena E, Tzouvelekis A, Tsigalou C, Voulgaris A, Xanthoudaki M, Mouemin T, Froudarakis M, Steiropoulos P.

Open Cardiovasc Med J. 2017 Dec 29;11:159-168. doi: 10.2174/1874192401711010159. eCollection 2017.

30.

Corrigendum: Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.

Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D.

Front Med (Lausanne). 2018 Jan 24;4:257. doi: 10.3389/fmed.2017.00257. eCollection 2017.

31.

Safety and efficacy of nintedanib in idiopathic pulmonary fibrosis: A real-life observational study in Greece.

Tzouvelekis A, Karampitsakos T, Kontou M, Granitsas A, Malliou I, Anagnostopoulos A, Ntolios P, Tzilas V, Bouros E, Steiropoulos P, Chrysikos S, Dimakou K, Koulouris N, Bouros D.

Pulm Pharmacol Ther. 2018 Apr;49:61-66. doi: 10.1016/j.pupt.2018.01.006. Epub 2018 Jan 31.

PMID:
29366978
32.

Longitudinal "Real-World" Outcomes of Pirfenidone in Idiopathic Pulmonary Fibrosis in Greece.

Tzouvelekis A, Karampitsakos T, Ntolios P, Tzilas V, Bouros E, Markozannes E, Malliou I, Anagnostopoulos A, Granitsas A, Steiropoulos P, Dimakou K, Chrysikos S, Koulouris N, Bouros D.

Front Med (Lausanne). 2017 Nov 29;4:213. doi: 10.3389/fmed.2017.00213. eCollection 2017. Erratum in: Front Med (Lausanne). 2018 Jan 24;4:257.

33.

Validation of the Greek version of the Severe Respiratory Insufficiency questionnaire.

Tsara V, Michailidis V, Perantoni E, Nena E, Moysiadis N, Windisch W, Steiropoulos P.

Hippokratia. 2017 Oct-Dec;21(4):186-190.

34.

Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.

Bouros E, Filidou E, Arvanitidis K, Mikroulis D, Steiropoulos P, Bamias G, Bouros D, Kolios G.

Pulm Pharmacol Ther. 2017 Oct;46:78-87. doi: 10.1016/j.pupt.2017.08.012. Epub 2017 Sep 1.

PMID:
28865842
35.

Safety and efficacy of pirfenidone in severe Idiopathic Pulmonary Fibrosis: A real-world observational study.

Tzouvelekis A, Ntolios P, Karampitsakos T, Tzilas V, Anevlavis S, Bouros E, Steiropoulos P, Koulouris N, Stratakos G, Froudarakis M, Bouros D.

Pulm Pharmacol Ther. 2017 Oct;46:48-53. doi: 10.1016/j.pupt.2017.08.011. Epub 2017 Aug 24.

PMID:
28843616
36.

Vitamin D Levels in Middle-Aged Patients with Obstructive Sleep Apnoea Syndrome.

Archontogeorgis K, Nena E, Papanas N, Zissimopoulos A, Voulgaris A, Xanthoudaki M, Manolopoulos V, Froudarakis M, Steiropoulos P.

Curr Vasc Pharmacol. 2018;16(3):289-297. doi: 10.2174/1570161115666170529085708.

PMID:
28552071
37.

Increased Carotid Intima-Media Thickness in Obstructive Sleep Apnea: An Additional Issue to Consider.

Steiropoulos P, Papanas N.

Angiology. 2017 Aug;68(7):569-570. doi: 10.1177/0003319717705270. Epub 2017 Apr 18. No abstract available.

PMID:
28415848
38.

Lung cancer in patients with idiopathic pulmonary fibrosis.

Karampitsakos T, Tzilas V, Tringidou R, Steiropoulos P, Aidinis V, Papiris SA, Bouros D, Tzouvelekis A.

Pulm Pharmacol Ther. 2017 Aug;45:1-10. doi: 10.1016/j.pupt.2017.03.016. Epub 2017 Apr 1. Review.

PMID:
28377145
39.

Cystatin C Levels in Middle-Aged Patients with Obstructive Sleep Apnea Syndrome.

Archontogeorgis K, Nena E, Tsigalou C, Voulgaris A, Xanthoudaki M, Froudarakis M, Steiropoulos P.

Pulm Med. 2016;2016:8081723. Epub 2016 Oct 24.

40.

Mounier-Kuhn Syndrome in an Elderly Female with Pulmonary Fibrosis.

Boglou P, Papanas N, Oikonomou A, Bakali S, Steiropoulos P.

Case Rep Med. 2016;2016:8708251. doi: 10.1155/2016/8708251. Epub 2016 Aug 15.

41.

Chronic kidney disease in European patients with obstructive sleep apnea: the ESADA cohort study.

Marrone O, Battaglia S, Steiropoulos P, Basoglu OK, Kvamme JA, Ryan S, Pepin JL, Verbraecken J, Grote L, Hedner J, Bonsignore MR; ESADA study group.

J Sleep Res. 2016 Dec;25(6):739-745. doi: 10.1111/jsr.12426. Epub 2016 May 18.

42.

Obstructive sleep apnea and cardiovascular disease: Is mean platelet volume one of the links?

Papanas N, Mikhailidis DP, Steiropoulos P.

Anatol J Cardiol. 2016 Mar;16(3):223. doi: 10.14744/AnatolJCardiol.2016.6902. No abstract available.

43.

An Unexpected Pulmonary Coin Lesion.

Karpathiou G, Batistatou A, Steiropoulos P, Stefanou D, Froudarakis ME.

Int J Surg Pathol. 2016 Jun;24(4):328-9. doi: 10.1177/1066896915623362. Epub 2015 Dec 21. No abstract available.

PMID:
26689689
44.

Mean Platelet Volume as a Surrogate Marker for Platelet Activation in Patients With Idiopathic Pulmonary Fibrosis.

Ntolios P, Papanas N, Nena E, Boglou P, Koulelidis A, Tzouvelekis A, Xanthoudaki M, Tsigalou C, Froudarakis ME, Bouros D, Mikhailidis DP, Steiropoulos P.

Clin Appl Thromb Hemost. 2016 May;22(4):346-50. doi: 10.1177/1076029615618023. Epub 2015 Dec 9.

PMID:
26659450
45.

Obstructive Sleep Apnea and Diabetic Foot: New Responsibilities?

Papanas N, Steiropoulos P.

Angiology. 2016 Aug;67(7):605-6. doi: 10.1177/0003319715599469. Epub 2015 Aug 10. No abstract available.

PMID:
26261377
46.

The relationship between obstructive sleep apnoea and coronary heart disease.

Pafili K, Steiropoulos P, Papanas N.

Curr Opin Cardiol. 2015 Jul;30(4):439-46. doi: 10.1097/HCO.0000000000000172. Review.

PMID:
26049394
47.

Obstructive Sleep Apnea and Atrial Fibrillation: Do They Synergistically Increase Cardiovascular Risk?

Steiropoulos P, Papanas N.

Angiology. 2015 Jul;66(6):501-2. doi: 10.1177/0003319714568446. Epub 2015 Jan 15. No abstract available.

PMID:
25593210
48.

Serum Levels of Vascular Endothelial Growth Factor and Insulin-like Growth Factor Binding Protein-3 in Obstructive Sleep Apnea Patients: Effect of Continuous Positive Airway Pressure Treatment.

Archontogeorgis K, Nena E, Papanas N, Xanthoudaki M, Hatzizisi O, Kyriazis G, Tsara V, Maltezos E, Froudarakis M, Steiropoulos P.

Open Cardiovasc Med J. 2015 Dec 29;9:133-8. doi: 10.2174/1874192401509010133. eCollection 2015.

49.

Biomarkers to improve diagnosis and monitoring of obstructive sleep apnea syndrome: current status and future perspectives.

Archontogeorgis K, Nena E, Papanas N, Steiropoulos P.

Pulm Med. 2014;2014:930535. doi: 10.1155/2014/930535. Epub 2014 Nov 27. Review.

50.

Pneumothorax in sarcoidosis.

Manika K, Kioumis I, Zarogoulidis K, Kougioumtzi I, Dryllis G, Pitsiou G, Machairiotis N, Katsikogiannis N, Lampaki S, Papaiwannou A, Zaric B, Branislav P, Huang H, Li Q, Steiropoulos P, Zarogoulidis P.

J Thorac Dis. 2014 Oct;6(Suppl 4):S466-9. doi: 10.3978/j.issn.2072-1439.2014.09.11. Review.

Supplemental Content

Loading ...
Support Center